BIOPTIMATE ApS: Financial statements 2020
CVR: 36051183
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BIOPTIMATE ApS (CVR 36051183) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -62,802 and a net result of DKK -59,527 compared with DKK -290,130 the year before. Equity in the 2020 report amounted to DKK -261,741.
- Gross Profit
- DKK -62,802
- Profit/Loss
- DKK -59,527
- Equity
- DKK -261,741
- Total Assets
- DKK 398,051
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -63 t. | -60 t. | -262 t. | 0 |
| 2019 | - | -294 t. | -290 t. | -202 t. | 1 |
| 2018 | - | 13 t. | 13 t. | 88 t. | - |
| 2017 | - | -20 t. | -24 t. | 75 t. | - |
| 2016 | - | -13 t. | 39 t. | 99 t. | - |
How creditworthy is BIOPTIMATE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 26, 2020, Nicolai Winding Andersen has joined the board of directors of BIOPTIMATE ApS.
BIOPTIMATE ApS has published its annual report for 2019. Gross profit came to DKK -294,043, and the net result was DKK -290,130.
About BIOPTIMATE ApS
BIOPTIMATE ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jens Christian Sørensen. The company is owned by Pure20 ApS. In 2025, the company reported a gross profit of DKK -1,252,436 and a net result of DKK -1,858,649 compared with DKK -6,367,118 the year before. Equity in the 2025 report amounted to DKK -5,714,314.